Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (4,143,055)	$ (4,007,317)
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash stock based compensation expense	1,138,244	1,931,790
Shares issued for services		5,573
Amortization of beneficial conversion feature’	114,684
Depreciation and amortization	12,827	9,722
Amortization of future compensation payable	625,000	203,333
Amortization of prepaid expenses	184,164
Interest expense		77,708
Changes in assets and liabilities:
Accounts receivable	9,888	57,445
Other receivable
Inventory	5,930	(5,930)
Prepaids and deposits	(141,421)	5,433
Long term receivables - net		(141,182)
Accounts payable	(150,604)	(48,155)
Accrued interest	231,152
Accrued expenses and compensation	68,125	(381,833)
Net cash used in operating activities	(2,045,066)	(2,293,413)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment		(4,410)
Net cash used in investing activities		(4,410)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from notes payable	4,456,760	2,150,000
Proceeds from issuance of common stock	1,644,100	150,000
Repayment on notes payable	(528,251)	(31,576)
Cancellation of Stock	(1,300,000)
Proceeds from the exercise of stock options and warrants	75,250
Net cash provided by financing activities	4,347,859	2,268,424
Net increase (decrease) in cash and cash equivalents	2,302,793	(29,399)
Cash and cash equivalents, beginning of period	88,415	178,552
Cash and cash equivalents, end of period	2,391,208	149,153
Supplemental Cash Flow Information
Cash paid for interest	53,976	2,117
Cash paid for taxes
Schedule of Non-Cash Information
Discount on note payable on purchase of Applied Optical Sciences		2,500,000
Amortization of discount on note payable		(28,333)
Note payable on purchase of Applied Optical Sciences		$ (2,500,000)
Beneficial conversion feature on notes payable	708,034
Non-cash accrual for payment on settlement	$ 500,000